China Pharma Holding Inc CPHI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CPHI is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.31
- Day Range
- $0.30–0.33
- 52-Week Range
- $0.27–2.18
- Bid/Ask
- $0.32 / $0.32
- Market Cap
- $17.07 Mil
- Volume/Avg
- 227,146 / 414,508
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.17
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 239
Valuation
|
Metric
|
CPHI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.49 |
Price/Sales | 0.17 |
Price/Cash Flow | — |
Price/Earnings
CPHI
Financial Strength
|
Metric
|
CPHI
|
|---|---|
Quick Ratio | 0.32 |
Current Ratio | 0.88 |
Interest Coverage | −8.25 |
Quick Ratio
CPHI
Profitability
|
Metric
|
CPHI
|
|---|---|
Return on Assets (Normalized) | −18.44% |
Return on Equity (Normalized) | −56.72% |
Return on Invested Capital (Normalized) | −21.92% |
Return on Assets
CPHI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yvlybqjrl | Nvqt | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Pzmtknhz | Ltyggxr | $72.9 Bil | |
HLN
| Haleon PLC ADR | Nnntykbst | Yhl | $37.5 Bil | |
VTRS
| Viatris Inc | Yfkmynkfb | Gpsv | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mygqbzl | Ghnxt | $11.7 Bil | |
CTLT
| Catalent Inc | Fnkfljhb | Cgxspc | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rdgscdlc | Kvgp | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Rzhxdfmrs | Blxt | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lzrqwwvb | Svdkjt | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Mpdzcqnjz | Xtd | $3.0 Bil |